Efficacy and safety of pyrotinib‐containing regimen in the patients with HER2‐positive metastatic breast cancer: A multicenter real‐world study
2022 · Cancer Medicine · 17 citations
https://doi.org/10.1002/cam4.5056
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
151
Citations
7
h-index
5
i10-index
Yajing Chi is an academic researcher from Ministry of Education. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Genetic factors in colorectal cancer & Cancer Immunotherapy and Biomarkers. The author has an h-index of 7, co-authored 16 publications.
https://doi.org/10.1002/cam4.5056
https://doi.org/10.1016/j.biomaterials.2025.123113
Click to start Chat